This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novo Nordisk A/s. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Berit Edsberg: Innovator in Diabetes Treatment
Introduction
Berit Edsberg is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of diabetes treatment through his innovative work on insulin derivatives. His research focuses on improving the administration of insulin for patients with diabetes mellitus.
Latest Patents
Edsberg holds a patent for "Treating diabetes mellitus using insulin injections with less than daily injection frequency." This invention relates to an insulin derivative designed for the treatment of conditions where insulin administration is beneficial. The insulin derivative allows for effective dosages to be administered at intervals longer than 24 hours, thereby providing a prolonged profile of action.
Career Highlights
Berit Edsberg is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has been instrumental in advancing treatment options for diabetes patients.
Collaborations
Edsberg has collaborated with notable colleagues, including Thue Johansen and Birgitte Koch Michelsen. Their combined expertise has contributed to the development of innovative solutions in diabetes management.
Conclusion
Berit Edsberg's contributions to diabetes treatment through his patented innovations highlight the importance of ongoing research and development in healthcare. His work continues to impact the lives of many patients in need of effective insulin therapies.